Jump to content
RemedySpot.com

Adult psychiatric drug OK'd for kids

Rate this topic


Guest guest

Recommended Posts

Adult psychiatric drug OK'd for kids

1 hour, 16 minutes ago

The Food and Drug Administration on Wednesday approved a widely used adult psychiatric drug for the treatment of schizophrenia and bipolar disorder in children and adolescents.

The action permits use of Risperdal for schizophrenia in youths aged 13 to 17 and for bipolar disorder for those aged 10 to 17, FDA said.

It was approved last fall for treatment of irritability in autism.

Risperdal, manufactured by Janssen, L.P. of Titusville, N.J., is the No. 3 anti-psychotic drug with $2.3 billion in sales in 2005, according to the pharmaceutical data company IMS Health.

Risperdal was approved for use in adults in 1993.

Until now, FDA said, there has been no approved drug for the treatment of schizophrenia in youths and only lithium is approved for the treatment of bipolar disorder in adolescents.

The dose approved for youths is slightly lower than the adult dose, FDA said.

Drowsiness, fatigue, increase in appetite, anxiety, nausea, dizziness, dry mouth, tremor, and rash were among the most common side effects reported, the agency said.

___

On the Net:

Food and Drug Administration: http://www.fda.gov

"Let food be thy medicine andlet medicine be thy food"http://vanokat.wholefoodfarmacy.com/2005/ga_home.asp

Link to comment
Share on other sites

We discussed this a few months ago.

Risperdal is useful in some autistic children. Right now my 12 year old

is on Abilify, which is a second generation of this type of drug. He is

doing remarkably well on it. He has had no side effects whatsoever.

For those of you who don’t know me as well, is on a diet that

excludes dairy, soy, sugar, chocolate, and cashews. I also do not allow

him anything with preservatives or artificial additives in it. He takes a

natural probiotic supplement daily and I make him rice or almond milk.

Hubby and I are discussing home schooling for him again as well.

Janet

From: health [mailto:health ] On Behalf Of Kathy

Sent: Wednesday, August 22, 2007

11:14 AM

Undisclosed-Recipient:;

Subject:

Adult psychiatric drug OK'd for kids

Adult

psychiatric drug OK'd for kids

1

hour, 16 minutes ago

The Food

and Drug Administration on Wednesday approved a widely used adult psychiatric

drug for the treatment of schizophrenia and bipolar disorder in children and

adolescents.

The

action permits use of Risperdal for schizophrenia in youths aged 13 to 17 and

for bipolar disorder for those aged 10 to 17, FDA said.

It was

approved last fall for treatment of irritability in autism.

Risperdal,

manufactured by Janssen, L.P. of Titusville,

N.J., is the No. 3 anti-psychotic

drug with $2.3 billion in sales in 2005, according to the pharmaceutical data

company IMS Health.

Risperdal

was approved for use in adults in 1993.

Until

now, FDA said, there has been no approved drug for the treatment of

schizophrenia in youths and only lithium is approved for the treatment of

bipolar disorder in adolescents.

The dose

approved for youths is slightly lower than the adult dose, FDA said.

Drowsiness,

fatigue, increase in appetite, anxiety, nausea, dizziness, dry mouth, tremor,

and rash were among the most common side effects reported, the agency said.

___

On the

Net:

Food and

Drug Administration: http://www.fda.gov

" Let food be thy medicine and

let medicine be thy food "

http://vanokat.wholefoodfarmacy.com/2005/ga_home.asp

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...